US biotech sector revenue is estimated to have grown on average >10% each year over the past decade—much faster than the rest of the economy. A more comprehensive assessment of biotech's economic contribution, however, will require improved data collection, classification and analysis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Synthetic acid stress-tolerance modules improve growth robustness and lysine productivity of industrial Escherichia coli in fermentation at low pH
Microbial Cell Factories Open Access 22 April 2022
-
Longitudinal study of the impact of three major regulations on the Korean pharmaceutical industry in the last 30 years
Health Research Policy and Systems Open Access 06 January 2022
-
An optimized growth medium for increased recombinant protein secretion titer via the type III secretion system
Microbial Cell Factories Open Access 15 February 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Organisation for Economic Cooperation and Development. Emerging Policy Issues in Synthetic Biology. (OECD, 2014).
Aggarwal, R.S. What's fueling the biotech engine—2012 to 2013. Nat. Biotechnol. 32, 32–39 (2014).
Morrison, C. & Lähteenmäki, R. Public biotech in 2014—the numbers. Nat. Biotechnol. 33, 703–709 (2015).
Carlson, R.H. Biology is Technology: The Promise, Peril, and New Business of Engineering Life. (Harvard University Press, 2010).
Sagal, M. Synthetic Biology for the Next Generation, A Symposium Under the Auspices of The National Academy of Sciences (12–13 June 2012).
La Merie Business Intelligence. Blockbuster Biologics 2012 https://www.pipelinereview.com/index.php/2013050850905/FREE-Reports/Blockbuster-Biologics-2012.html (9 May 2013).
International Federation of Pharmaceutical Manufacturers and Associations. The Pharmaceutical Industry and Global Health: Facts and Figures 2012 http://www.ifpma.org/fileadmin/content/Publication/2013/IFPMA_-_Facts_And_Figures_2012_LowResSinglePage.pdf (IFPMA, 2012).
Carlson, R. Causes and Consequences of Bioeconomic Proliferation: Implications for U.S. Physical and Economic Security (Homeland Security Institute, 2011).
James, C. Global Status of Commercialized Biotech/GM Crops: 2012. ISAA brief 44 (ISAAA, 2012).
Carlson, R. The market value of GM products. Nat. Biotechnol. 27, 984–984 (2009).
Committee on the Impact of Biotechnology on Farm-Level Economics and Sustainability, Board on Agriculture and Natural Resources, Division on Earth and Life Studies, National Research Council. Impact of Genetically Engineered Crops on Farm Sustainability in the United States (The National Academies Press, 2010).
Brookes, G. & Barfoot, P. The global income and production effects of genetically modified (GM) crops 1996–2011. GM Crops Food 4, 74–83 (2013).
Klümper, W. & Qaim, M. A meta-analysis of the impacts of genetically modified crops. PLoS One 9, e111629 (2014).
Fernandez-Cornejo, J., Wechsler, S., Livingston, M. & Mitchell, L. Genetically Engineered Crops in the United States http://www.ers.usda.gov/publications/err-economic-research-report/err162.aspx (USDA ERS, 2014).
Solomon, D. U.S. Congressional Briefing: Tooling the Bioeconomy (US Congress, Washington, DC, November 5, 2013). https://vimeo.com/album/2662670
National Mining Association. The Economic Contributions of U.S. Mining (2012) http://www.nma.org/pdf/economic_contributions.pdf (National Mining Association, 2014).
Battelle/BIO. Battelle/BIO State Bioscience Jobs, Investments and Innovation 2014 (Biotechnology Industry Organization, 2014).
Anonymous. How big is the bioeconomy? Nat. Biotechnol. 32, 598 (2014).
Biotechnology Industry Organization. Unleashing the Promise of Biotechnology https://www3.bio.org/aboutbio/promiseofbiotech.pdf (BIO, 2011).
Office of the Chief Economist and Office of Energy Policy and New Uses. Biobased Economy Indicators (USDA, 2011).
Batchelor, S. New Opportunities: Renewable Chemicals and Biobased Products http://energyoutlook2012.naseo.org/presentations/Batchelor-Renewable_Chemicals_and-Biobased_Products.pdf (NASEO Winter Policy Outlook Conference, 8 February 2012).
European Commission. Innovating for Sustainable Growth: A Bioeconomy for Europe http://ec.europa.eu/research/bioeconomy/pdf/201202_innovating_sustainable_growth_en.pdf (European Commission, 2012).
Carlson, R. From national security to natural security. Bulletin of the Atomic Scientists http://thebulletin.org/national-security-natural-security/ (11 December 2013)
Pimentel, D., Zuniga, R. & Morrison, D. Update on the environmental and economic costs associated with alien-invasive species in the United States. Integrating Ecol. Econ. Control Bioinvasions IEECB SI 52, 273–288 (2005).
Goodell, J. Goodbye Miami. Rolling Stone (20 June 2013).
Anonymous. You're going to get wet. The Economist (25 June 2013).
Campo-Flores, A. Flood fixes vex coastal areas. The Wall Street Journal (13 June 2013).
Williams, V.J. Identifying the economic effects of salt water intrusion after Hurricane Katrina. J. Sustain. Dev. 3, 29–37 (2010).
BenDor, T., Lester, T.W., Livengood, A., Davis, A. & Yonavjak, L. Estimating the size and impact of the ecological restoration economy. PLoS ONE 10, e0128339 (2015).
Carlson, R. The pace and proliferation of biological technologies. Biosecur. Bioterr. 1, 203–214 (2004).
Carlson, R. The Causes and Consequences of Bioeconomic Proliferation: Implications for U.S. Physical and Economic Security (Homeland Security Institute, 2012).
US National Security Council. National Strategy for Countering Biological Threats. (Office of the President of the United States, 2009).
Ledford, H. Garage biotech: life hackers. Nature 467, 650–652 (2010).
Carvalho, D.O. et al. Suppression of a field population of Aedes aegypti in Brazil by sustained release of transgenic male mosquitoes. PLoS Negl. Trop. Dis. 9, e0003864 (2015).
Ezezika, O.C. & Singer, P.A. Genetically engineered oil-eating microbes for bioremediation: Prospects and regulatory challenges. Technol. Soc. 32, 331–335 (2010).
Gisbert, C. et al. A plant genetically modified that accumulates Pb is especially promising for phytoremediation. Biochem. Biophys. Res. Commun. 303, 440–445 (2003).
US Office of Management and Budget. North American Industry Classification System (NAICS)—updates for 2017. Fed. Regist. 79, 29626–29629 (2014).
Acknowledgements
I am grateful to R. Langer, R. Wehbring, M. Oliveira and E. Carlson for their excellent comments and questions. Early portions of this work were funded by the Homeland Security Institute, the Defense Threat Reduction Agency and Biodesic, LLC.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.C. is the Managing Director of an investment fund that operates in biotechnology.
Supplementary information
Source data
Rights and permissions
About this article
Cite this article
Carlson, R. Estimating the biotech sector's contribution to the US economy. Nat Biotechnol 34, 247–255 (2016). https://doi.org/10.1038/nbt.3491
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3491
This article is cited by
-
Longitudinal study of the impact of three major regulations on the Korean pharmaceutical industry in the last 30 years
Health Research Policy and Systems (2022)
-
Synthetic acid stress-tolerance modules improve growth robustness and lysine productivity of industrial Escherichia coli in fermentation at low pH
Microbial Cell Factories (2022)
-
The Worldview national ranking of health biotech sectors
Nature Biotechnology (2022)
-
Conceptual evolution of the bioeconomy: a bibliometric analysis
Environment, Development and Sustainability (2022)
-
An optimized growth medium for increased recombinant protein secretion titer via the type III secretion system
Microbial Cell Factories (2021)